Stock comparison
Moderna, Inc. is 4.4x more valuable than Scholar Rock Holding Corp by market capitalization ($30.38 B vs $6.94 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRNA is larger
Moderna, Inc. is 4.4x more valuable than Scholar Rock Holding Corp by market capitalization ($30.38 B vs $6.94 B).
Market value leader
MRNA
Moderna, Inc. is 4.4x more valuable than Scholar Rock Holding Corp by market capitalization ($30.38 B vs $6.94 B).
Revenue leader
MRNA
SRRK: $0.00 vs MRNA: $1.94B.
Profit leader
SRRK
SRRK: -$378.00M vs MRNA: -$2.82B.
| Metric | SRRK | MRNA |
|---|---|---|
| Market cap | $6.94 B | $30.38 B |
| US-listed rank | #1175 | #461 |
| Revenue (latest FY) | $0.00 | $1.94B |
| Net income (latest FY) | -$378.00M | -$2.82B |
| Net margin | - | -145.2% |
| P/E (trailing FY) | - | - |
| SEC filings | 618 | 1,447 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Moderna, Inc. is 4.4x more valuable than Scholar Rock Holding Corp by market capitalization ($30.38 B vs $6.94 B).
In their latest fiscal years, Scholar Rock Holding Corp reported $0.00 in revenue while Moderna, Inc. reported $1.94B.
Full pages: Scholar Rock Holding Corp and Moderna, Inc., or browse the full rankings.